Latest papers

Whole cancer genome sequencing by next-generation methods.

Perspectives on human population structure at the cusp of the sequencing era.

LINE-1 elements in structural variation and disease.

Unraveling the genetics of cancer: genome sequencing and beyond.

Personalized medicine: progress and promise.

Regulation of C-type natriuretic peptide expression.

[Coping with ubiquitous DNA testing]. FAU - Jordan, Bertrand AU - Jordan B LA - fre PT - Editorial TT - Maitriser la generalisation des test genetiques. PL - France TA - Med Sci (Paris) JT - Medecine sciences : M/S JID - 8710980 RN - 9007-49-2 (DNA) SB - IM MHDA- 2011/09/13 06:00 PST - ppublish SO - Med Sci (Paris). 2011 Jun-Jul;27(6-7):567-8.

VPS35 Mutations in Parkinson Disease

Schizophrenia risk genes: Implications for future drug development and discovery.

Exome sequencing identifies ZNF644 mutations in high myopia.

Direct-to-consumer genomewide profiling.

Direct-to-consumer genomewide profiling.

2 -deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2 -deoxy-5-azacytidine: a comparative study of hypomethylating potential.

Determination of genomic 5-hydroxymethyl-2'-deoxycytidine in human DNA by capillary electrophoresis with laser induced fluorescence.

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.

Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research.

[Genetic tools]. AD - Hospices civils de Lyon, service de genetique moleculaire, Lyon. FAU - Boutry-Kryza, Nadia AU - Boutry-Kryza N FAU - Sanlaville, Damien AU - Sanlaville D LA - fre PT - Journal Article TT - Les outils de la genetique. PL - France TA - Rev Prat JT - La Revue du praticien JID - 0404334 SB - IM MHDA- 2011/06/29 06:00 PST - ppublish SO - Rev Prat. 2011 Apr;61(4):526-7.

[Publishing impulsivity...].

Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling.